DE60330949D1 - Therapeutisches system für die kontrollierte freisetzung von wirkstoffen - Google Patents

Therapeutisches system für die kontrollierte freisetzung von wirkstoffen

Info

Publication number
DE60330949D1
DE60330949D1 DE60330949T DE60330949T DE60330949D1 DE 60330949 D1 DE60330949 D1 DE 60330949D1 DE 60330949 T DE60330949 T DE 60330949T DE 60330949 T DE60330949 T DE 60330949T DE 60330949 D1 DE60330949 D1 DE 60330949D1
Authority
DE
Germany
Prior art keywords
active substances
release
tablet
constituted
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60330949T
Other languages
German (de)
English (en)
Inventor
Lauretta Maggi
Ubaldo Conte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Application granted granted Critical
Publication of DE60330949D1 publication Critical patent/DE60330949D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60330949T 2002-03-12 2003-03-12 Therapeutisches system für die kontrollierte freisetzung von wirkstoffen Expired - Lifetime DE60330949D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI000514A ITMI20020514A1 (it) 2002-03-12 2002-03-12 Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
PCT/EP2003/002536 WO2003075897A1 (en) 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients

Publications (1)

Publication Number Publication Date
DE60330949D1 true DE60330949D1 (de) 2010-03-04

Family

ID=11449490

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60330949T Expired - Lifetime DE60330949D1 (de) 2002-03-12 2003-03-12 Therapeutisches system für die kontrollierte freisetzung von wirkstoffen

Country Status (12)

Country Link
US (1) US20050095295A1 (cg-RX-API-DMAC7.html)
EP (1) EP1482915B1 (cg-RX-API-DMAC7.html)
JP (1) JP4664595B2 (cg-RX-API-DMAC7.html)
CN (1) CN100528146C (cg-RX-API-DMAC7.html)
AT (1) ATE454887T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003239789A1 (cg-RX-API-DMAC7.html)
CA (1) CA2478406C (cg-RX-API-DMAC7.html)
DE (1) DE60330949D1 (cg-RX-API-DMAC7.html)
DK (1) DK1482915T3 (cg-RX-API-DMAC7.html)
ES (1) ES2339438T3 (cg-RX-API-DMAC7.html)
IT (1) ITMI20020514A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003075897A1 (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003024429A1 (en) 2001-09-21 2003-03-27 Egalet A/S Polymer release system
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
US8877241B2 (en) 2003-03-26 2014-11-04 Egalet Ltd. Morphine controlled release system
ATE551051T1 (de) * 2003-09-19 2012-04-15 Sun Pharma Advanced Res Co Ltd Orales arzneimittelabgabesystem
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
CA2607272A1 (en) * 2005-05-09 2006-11-16 Azur Pharma Limited Formulations of mast cell stabilizing agents for delivery to the colon
NZ563846A (en) * 2005-06-03 2010-03-26 Egalet As A drug delivery system for delivering active substances dispersed in a dispersion medium
BRPI0520797B8 (pt) * 2005-11-18 2021-05-25 Accu Break Tech Inc forma de dosagem farmacêutica comprimida em bicamadas
CA2657437A1 (en) * 2006-06-19 2007-12-27 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
CA2715584A1 (en) * 2008-02-15 2009-10-08 Sun Pharma Advanced Research Company Ltd. Oral controlled release tablet
AU2009308885A1 (en) * 2008-10-31 2010-05-06 Mcneil-Ppc, Inc. Osmotic tablet with a compressed outer coating
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
ES2607209T3 (es) 2009-02-06 2017-03-29 Egalet Ltd. Composiciones farmacéuticas resistentes al abuso
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
US9622979B2 (en) * 2011-06-29 2017-04-18 Sun Pharmaceutical Industries Limited Multilayered dosage form
JP2015521988A (ja) 2012-07-06 2015-08-03 イガレット・リミテッド 制御放出用乱用防止性医薬組成物
CN104490838B (zh) * 2014-11-20 2017-03-01 河北医科大学 一种骨架型缓控释片剂及其制备方法和应用
CN108697700B (zh) 2016-02-04 2021-08-17 辛多美制药有限公司 氘代多潘立酮组合物和用于治疗病症的方法
US11364226B2 (en) 2017-06-30 2022-06-21 Cinrx Pharma, Llc Deuterated domperidone compositions, methods, and preparation
AU2017261372B2 (en) * 2016-05-05 2019-02-14 Triastek, Inc. Controlled release dosage form
AU2018231044B2 (en) 2017-03-08 2023-04-06 Cinrx Pharma, Llc Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol
US12478612B2 (en) 2017-06-30 2025-11-25 Cindome Pharma, Inc. Deuterated domperidone compositions, methods, and preparation
JP7034343B2 (ja) * 2018-06-27 2022-03-11 アムニール コンプレックス プロダクツ リサーチ エルエルシー 自己調節性の浸透性胃保持性薬物送達システム
WO2020027927A1 (en) * 2018-07-30 2020-02-06 Insta Therapeutics, Inc. Sublingual diltiazem and methods of use
CN113274363B (zh) * 2021-04-29 2023-02-10 珠海润都制药股份有限公司 一种吲达帕胺制剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4503030A (en) * 1983-06-06 1985-03-05 Alza Corporation Device for delivering drug to certain pH environments
IT1201136B (it) * 1987-01-13 1989-01-27 Resa Farma Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5376771A (en) * 1992-07-07 1994-12-27 Merck & Co., Inc. High speed process for preparing orifices in pharmaceutical dosage forms
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
CN2213539Y (zh) * 1994-04-29 1995-11-29 天津市激光技术研究所 包衣上带有小孔的缓释药片
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US5783793A (en) * 1996-02-29 1998-07-21 Merck & Co., Inc. Process for producing a plurality of holes in dosage forms using a laser beam deflected by an acousto-optic deflector
US6004582A (en) * 1997-05-30 1999-12-21 Laboratorios Phoenix U.S.A, Inc. Multi-layered osmotic device
US6004584A (en) * 1998-03-02 1999-12-21 The Procter & Gamble Company Highly absorbent body powders
JP2003504415A (ja) * 1999-07-20 2003-02-04 メルク エンド カムパニー インコーポレーテッド 持続放出性薬物分散剤輸送装置
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento

Also Published As

Publication number Publication date
CA2478406C (en) 2011-02-08
AU2003239789A1 (en) 2003-09-22
JP2005526757A (ja) 2005-09-08
JP4664595B2 (ja) 2011-04-06
ES2339438T3 (es) 2010-05-20
CN1649571A (zh) 2005-08-03
ITMI20020514A0 (it) 2002-03-12
US20050095295A1 (en) 2005-05-05
EP1482915B1 (en) 2010-01-13
DK1482915T3 (da) 2010-04-19
CA2478406A1 (en) 2003-09-18
CN100528146C (zh) 2009-08-19
ITMI20020514A1 (it) 2003-09-12
WO2003075897A1 (en) 2003-09-18
ATE454887T1 (de) 2010-01-15
EP1482915A1 (en) 2004-12-08

Similar Documents

Publication Publication Date Title
ATE454887T1 (de) Therapeutisches system für die kontrollierte freisetzung von wirkstoffen
Janczura et al. The development of innovative dosage forms of the fixed-dose combination of active pharmaceutical ingredients
JP2005526757A5 (cg-RX-API-DMAC7.html)
ES2524696T3 (es) Vendaje del tejido de la mucosa y método de uso
DE69918310D1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
AR005282A1 (es) Composición farmacéutica oral en la forma de un comprimido de unidades múltiples, uso de la misma para la preparación de medicamnetos, y procedimiento para su manufactura.
WO1998047561A1 (de) Vorrichtung zum behandeln von malignen, tumorösen gewebebereichen
DE602004006497D1 (de) Wasserlösliches abgabeprodukt
KR900011486A (ko) 하이드로겔에 의해 작동되는 분배장치
BR0315023A (pt) Distribuidor de composição anti-séptica de pele e método de preparar um distribuidor de composição anti-séptica de pele para uso
AR002275A1 (es) Forma de dosificacion farmaceutica oral, procedimiento para la manufactura de una forma de dosificacion fija, y uso de dicha forma de dosificacionfarmaceutica oral.
ATE446087T1 (de) Mikrokügelchen mit nanokapseln, die ein lipophiles arzneimittel enthalten
CO6290635A2 (es) Composición farmaceútica que comprende una forma de dosis unitaria sólida de uno o más ingredientes activos y un polímero insoluble en agua y/o un polímero soluble en agua
ES2174073T3 (es) Forma farmaceutica solida para uso oral.
AR033418A1 (es) Preparado farmaceutico mucoadhesivo desintegrable para la administracion de sustancia activa en medicina veterinaria y humana
AR034517A1 (es) Formulacion farmaceutica
DK0406779T3 (da) Indretning til afgivelse af systemiske virksomme stoffer til planter og anvendelse heraf
US20130035632A1 (en) Decomposable Apparatus and Methods for Fabricating Same
ATE534345T1 (de) Endovaskuläre vorrichtung mit membran
BRPI0812332A2 (pt) Embalagem para produtos de tabaco, e, método para fabricar a mesma
AR048050A1 (es) Formas de administracion masticables, no comprimidas, dosificadas individualmente
PA8548301A1 (es) Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion
WO2003075894A8 (en) A system for the controlled release of active ingredients
PT1079867E (pt) Metodo de fabrico de um componente em po de um adesivo para utilizacao medica, utilizacao do referido componente em po e o referido componente em po
ES2149341T3 (es) Expulsion de un material a partir de un dispositivo de liberacion.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition